Pain, PostoperativeNCT03499730
Does Midazolam Affect Postoperative Pain?
An observational study of Pain, Postoperative, run by Universidade do Porto at 4 sites in Portugal.
Trial summary
To investigate whether midazolam has any effect on postoperative pain in outpatient surgery, the investigators will assess the impact of different midazolam doses on pain scores 24h, 7 days and 3 months after open inguinal hernia repair. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pain, Postoperative
- What is being tested?
- Midazolam injection
- Type of treatment
- Injection or infusion
- How many people
- 300 participants
- Where
- 4 sitesPortugal
- Study dates
- 12 Sep 2018to 5 Mar 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Consecutive adult patients proposed for open inguinal hernia repair in Portuguese ambulatory surgery units, under general or spinal anesthesia.
Who may be able to join
- adults proposed for open inguinal hernia repair in Portuguese ambulatory surgery units
Who cannot join
- psychiatric disorders
- alcoholism
- illiteracy or poor understanding of the Portuguese language
- history of chronic pain under opioids
- recurrent surgery
Trial locations and contacts
4 sites in 1 country.
Portugal4 sites
Centro Hospitalar Baixo Vouga, EPE
Aveiro
Centro Hospitalar Universitário do Algarve
Faro
Centro Hospitalar Entre Douro e Vouga, EPE
Santa Maria da Feira
Centro Hospitalar Vila Nova de Gaia / Espinho, EPE
Vila Nova de Gaia
About this study
Official title: Does Preoperative Midazolam Dose Affect Postoperative Pain? - a Multicentric Observational Study in Open Inguinal Hernia Repair
To investigate whether midazolam has any effect on postoperative pain in outpatient surgery, the investigators will assess the impact of different midazolam doses on pain scores 24h, 7 days and 3 months after open inguinal hernia repair.
The investigators hypothesize that patients being administered higher midazolam doses will refer more pain.
Read the detailed description
Systemic midazolam prescribed perioperatively might have impact on pain, with studies suggesting antinociceptive and hyperalgesic effects. Anxiety might be a confounder in this association. In order to investigate the effect of midazolam on postoperative pain, a prospective cohort study will be conducted in four Portuguese ambulatory surgery units. A convenience sample with consecutive design will include patients admitted for open inguinal hernia repair. After anxiety and pain evaluation, a tailored dose of midazolam will be administered as premedication according to the anesthetist's best judgement within each unit's protocol (routine care; this dose may be null). Subsequent anesthesia and analgesia will be standardized. Postoperative pain will be blindly assessed by telephone interviews at 24h, 7 days, and 3 months. Statistical analysis will be performed separately for each gender, centre and type of anesthesia, adjusting for preoperative anxiety and other confounding variables with multivariate analysis.
The investigators intend to clarify the relation between anxiety, preoperative midazolam and postoperative pain.
- Conditions
- Pain, Postoperative
- Being tested
- Midazolam injection
- Keywords
- Midazolam, Inguinal hernia
- Medical subject headings
- Pain, Postoperative, Hernia, Inguinal
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Midazolam injectionDrug
The dose of preoperative midazolam is the predictor variable and will be registered as a continuous variable in a single cohort.
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative pain
Pain numeric rating scale (NRS) 0-10
Measured: 24h after surgery
Secondary outcomes (8)
Postoperative pain
Pain NRS
Measured: 7 days after surgery
Postoperative pain
Pain NRS
Measured: 3 months after surgery
Patient satisfaction
NRS
Measured: 7 days after surgery
Patient satisfaction
NRS
Measured: 3 months after surgery
Analgesic consumption
Total analgesic drugs taken in a time period
Measured: 24h after surgery
Analgesic consumption
Total analgesic drugs taken in a time period
Measured: 7 days after surgery
Adverse events
Number of patients with adverse events like bleeding, nausea, uncontrolled pain
Measured: 7 days after surgery
Global surgery recovery index
Global surgery recovery index
Measured: 3 months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2018
- Study start12 Sep 2018
- Primary completion5 Jun 2020
- Study completion5 Mar 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Pain, PostoperativeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidade do Porto
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Caroline Dahlem, Universidade do Porto
- Investigators
- Caroline Dahlem, MD, Principal investigator, UPorto /CINTESIS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03499730
- Sponsor's protocol ID
- Midazolam OBS
- Status last verified
- May 2021
- First submitted
- 9 Apr 2018
- Last updated
- 18 May 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data that underlie the results reported in this article might be shared with other researchers after deidentification.
Publications
Mantegazza P, Parenti M, Tammiso R, Vita P, Zambotti F, Zonta N. Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam. Br J Pharmacol. 1982 Apr;75(4):569-72. doi: 10.1111/j.1476-5381.1982.tb09175.x.
PubMed 6121598Okulicz-Kozaryn I, Kaminska E, Luczak J, Szczawinska K, Kotlinska-Lemieszek A, Baczyk E, Mikolajczak P. The effects of midazolam and morphine on analgesic and sedative activity of ketamine in rats. J Basic Clin Physiol Pharmacol. 2000;11(2):109-25. doi: 10.1515/jbcpp.2000.11.2.109.
PubMed 11037766Tatsuo MA, Salgado JV, Yokoro CM, Duarte ID, Francischi JN. Midazolam-induced hyperalgesia in rats: modulation via GABA(A) receptors at supraspinal level. Eur J Pharmacol. 1999 Apr 1;370(1):9-15. doi: 10.1016/s0014-2999(99)00096-5.
PubMed 10323274Frolich MA, Zhang K, Ness TJ. Effect of sedation on pain perception. Anesthesiology. 2013 Mar;118(3):611-21. doi: 10.1097/ALN.0b013e318281592d.
PubMed 23314164Kain ZN, Sevarino F, Pincus S, Alexander GM, Wang SM, Ayoub C, Kosarussavadi B. Attenuation of the preoperative stress response with midazolam: effects on postoperative outcomes. Anesthesiology. 2000 Jul;93(1):141-7. doi: 10.1097/00000542-200007000-00024.
PubMed 10861157Coulthard P, Rood JP. An investigation of the effect of midazolam on the pain experience. Br J Oral Maxillofac Surg. 1992 Aug;30(4):248-51. doi: 10.1016/0266-4356(92)90268-n.
PubMed 1510899Day MA, Rich MA, Thorn BE, Berbaum ML, Mangieri EA. A placebo-controlled trial of midazolam as an adjunct to morphine patient-controlled analgesia after spinal surgery. J Clin Anesth. 2014 Jun;26(4):300-8. doi: 10.1016/j.jclinane.2013.12.011. Epub 2014 Jun 2.
PubMed 24882605Hasani A, Maloku H, Sallahu F, Gashi V, Ozgen SU. Preemptive analgesia with midazolam and diclofenac for hernia repair pain. Hernia. 2011 Jun;15(3):267-72. doi: 10.1007/s10029-010-0772-y. Epub 2010 Dec 28.
PubMed 21188440Ong CK, Seymour RA, Tan JM. Sedation with midazolam leads to reduced pain after dental surgery. Anesth Analg. 2004 May;98(5):1289-93, table of contents. doi: 10.1213/01.ane.0000111107.18755.cc.
PubMed 15105203Dahlem CS, Monteiro CT, Mendes E, Oliveira CC, Bettencourt M, Azevedo L, Berger-Estilita J, Granja C. Comparing two pre-operative anxiety scales for predicting postoperative pain in ambulatory surgery: Data from a multicentre observational study. Eur J Anaesthesiol Intensive Care. 2026 Mar 30;5(3):e0102. doi: 10.1097/EA9.0000000000000102. eCollection 2026 Jun.
PubMed 42244825
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does Preoperative Midazolam Dose Affect Postoperative Pain? - a Multicentric Observational Study in Open Inguinal Hernia Repair
- ClinicalTrials.gov ID
- NCT03499730
- Acronym / sponsor ID
- Midazolam OBS
- Conditions
- Pain, Postoperative
- Keywords
- Midazolam, Inguinal hernia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 300 participants (actual)
- Lead sponsor
- Universidade do PortoUniversity, hospital or other
- Study start
- 12 Sep 2018 (actual)
- Primary completion
- 5 Jun 2020 (actual)
- Study completion
- 5 Mar 2021 (actual)
- First posted
- 17 Apr 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To investigate whether midazolam has any effect on postoperative pain in outpatient surgery, the investigators will assess the impact of different midazolam doses on pain scores 24h, 7 days and 3 months after open inguinal hernia repair.
The investigators hypothesize that patients being administered higher midazolam doses will refer more pain.
Detailed description
Systemic midazolam prescribed perioperatively might have impact on pain, with studies suggesting antinociceptive and hyperalgesic effects. Anxiety might be a confounder in this association. In order to investigate the effect of midazolam on postoperative pain, a prospective cohort study will be conducted in four Portuguese ambulatory surgery units. A convenience sample with consecutive design will include patients admitted for open inguinal hernia repair. After anxiety and pain evaluation, a tailored dose of midazolam will be administered as premedication according to the anesthetist's best judgement within each unit's protocol (routine care; this dose may be null). Subsequent anesthesia and analgesia will be standardized. Postoperative pain will be blindly assessed by telephone interviews at 24h, 7 days, and 3 months. Statistical analysis will be performed separately for each gender, centre and type of anesthesia, adjusting for preoperative anxiety and other confounding variables with multivariate analysis.
The investigators intend to clarify the relation between anxiety, preoperative midazolam and postoperative pain.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Consecutive adult patients proposed for open inguinal hernia repair in Portuguese ambulatory surgery units, under general or spinal anesthesia.
Key inclusion criteria (1 listed)
- adults proposed for open inguinal hernia repair in Portuguese ambulatory surgery units
Key exclusion criteria (5 listed)
- psychiatric disorders
- alcoholism
- illiteracy or poor understanding of the Portuguese language
- history of chronic pain under opioids
- recurrent surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Midazolam injectionThe dose of preoperative midazolam is the predictor variable and will be registered as a continuous variable in a single cohort. | Drug | – |
Primary outcome
Postoperative pain
Time frame: 24h after surgery
Pain numeric rating scale (NRS) 0-10
8 secondary outcomes
Postoperative pain
Time frame: 7 days after surgery
Postoperative pain
Time frame: 3 months after surgery
Patient satisfaction
Time frame: 7 days after surgery
Patient satisfaction
Time frame: 3 months after surgery
Analgesic consumption
Time frame: 24h after surgery
Analgesic consumption
Time frame: 7 days after surgery
Adverse events
Time frame: 7 days after surgery
Global surgery recovery index
Time frame: 3 months after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2021.
- Background: PubMed 6121598Mantegazza P, Parenti M, Tammiso R, Vita P, Zambotti F, Zonta N. Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam. Br J Pharmacol. 1982 Apr;75(4):569-72. doi: 10.1111/j.1476-5381.1982.tb09175.x.
- Background: PubMed 11037766Okulicz-Kozaryn I, Kaminska E, Luczak J, Szczawinska K, Kotlinska-Lemieszek A, Baczyk E, Mikolajczak P. The effects of midazolam and morphine on analgesic and sedative activity of ketamine in rats. J Basic Clin Physiol Pharmacol. 2000;11(2):109-25. doi: 10.1515/jbcpp.2000.11.2.109.
- Background: PubMed 10323274Tatsuo MA, Salgado JV, Yokoro CM, Duarte ID, Francischi JN. Midazolam-induced hyperalgesia in rats: modulation via GABA(A) receptors at supraspinal level. Eur J Pharmacol. 1999 Apr 1;370(1):9-15. doi: 10.1016/s0014-2999(99)00096-5.
- Background: PubMed 23314164Frolich MA, Zhang K, Ness TJ. Effect of sedation on pain perception. Anesthesiology. 2013 Mar;118(3):611-21. doi: 10.1097/ALN.0b013e318281592d.
- Background: PubMed 10861157Kain ZN, Sevarino F, Pincus S, Alexander GM, Wang SM, Ayoub C, Kosarussavadi B. Attenuation of the preoperative stress response with midazolam: effects on postoperative outcomes. Anesthesiology. 2000 Jul;93(1):141-7. doi: 10.1097/00000542-200007000-00024.
- Background: PubMed 1510899Coulthard P, Rood JP. An investigation of the effect of midazolam on the pain experience. Br J Oral Maxillofac Surg. 1992 Aug;30(4):248-51. doi: 10.1016/0266-4356(92)90268-n.
- Background: PubMed 24882605Day MA, Rich MA, Thorn BE, Berbaum ML, Mangieri EA. A placebo-controlled trial of midazolam as an adjunct to morphine patient-controlled analgesia after spinal surgery. J Clin Anesth. 2014 Jun;26(4):300-8. doi: 10.1016/j.jclinane.2013.12.011. Epub 2014 Jun 2.
- Background: PubMed 21188440Hasani A, Maloku H, Sallahu F, Gashi V, Ozgen SU. Preemptive analgesia with midazolam and diclofenac for hernia repair pain. Hernia. 2011 Jun;15(3):267-72. doi: 10.1007/s10029-010-0772-y. Epub 2010 Dec 28.
- Background: PubMed 15105203Ong CK, Seymour RA, Tan JM. Sedation with midazolam leads to reduced pain after dental surgery. Anesth Analg. 2004 May;98(5):1289-93, table of contents. doi: 10.1213/01.ane.0000111107.18755.cc.
- Derived from this study: PubMed 42244825Dahlem CS, Monteiro CT, Mendes E, Oliveira CC, Bettencourt M, Azevedo L, Berger-Estilita J, Granja C. Comparing two pre-operative anxiety scales for predicting postoperative pain in ambulatory surgery: Data from a multicentre observational study. Eur J Anaesthesiol Intensive Care. 2026 Mar 30;5(3):e0102. doi: 10.1097/EA9.0000000000000102. eCollection 2026 Jun.
- Individual participant dataSharing planned: Yes. Individual participant data that underlie the results reported in this article might be shared with other researchers after deidentification.
Related trials for Pain, Postoperative
Recruiting
US Guided EOI Block Versus ESPB for Postoperative Analgesia in Laparoscopic Cholecystectomy
Postoperative Pain
Active, not recruitingObservational study
The Effect of Single Lung Ventilation Duration and Intraoperative Brain Oxygenation on Cognitive Function and Postoperative Pain in Geriatric Patients
Thoracic Anesthesia, Geriatric Anesthesia
Recruiting
Tramadol Versus Morphine for Postoperative Pain Relief Following Laparoscopic Abdominal Surgery
Multimodal Analgesia, Tramadol
Recruiting
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
Gastric Cancer (GC), Stomach Neoplasms
Active, not recruitingObservational study
Return to Physical Activity After Retropublic Transvaginal Sling and Laparoscopic Sacrocolpopexy
Stress Urinary Incontinence, Pelvic Organ Prolapse
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Caroline Dahlem, MD principal investigator
UPorto /CINTESIS
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pain, Postoperative, run by Universidade do Porto at 4 sites in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 May 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative pain (time frame: 24h after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03499730, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2021.